Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma
Vincristine, Etoposide and Cyclosporine A in Concert With Standard Dose Radiation Therapy in Diffuse Intrinsic Brain Stem Glioma - A Phase I Study of Dose Escalation of Vincristine
3 other identifiers
interventional
7
5 countries
74
Brief Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy plus radiation therapy in treating patients with newly diagnosed brain stem glioma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Dec 1998
Longer than P75 for phase_1
74 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 1998
CompletedFirst Submitted
Initial submission to the registry
November 1, 1999
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2001
CompletedFirst Posted
Study publicly available on registry
September 13, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2006
CompletedJuly 28, 2014
July 1, 2014
2.2 years
November 1, 1999
July 25, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Event Free Survival
Study Arms (1)
Stratum 1
EXPERIMENTALConcomitant irradiation and vincristine sulfate in esc dose beginning with 0.8 mg/m2, etoposide and Cyclosporine A given over 6 weeks, then monthly maint courses over 6 mths, with no clinical and radiologic progression. Stable disease indicates continuation of therapy. Clinical deterioration within 4 months of completion of radiation therapy must be confirmed to be PD by imaging. Clinical progression even in the absence of imaging changes will be accepted as reflecting disease progression. Steroids dexamethasone (Decadron) given as clinically indicated and tapered as tolerated. Steroids may decrease capillary permeability to chemotherapeutic agents and antagonise the effect of cyclosporin A. Also contributes to the syndrome of seizures and white matter changes seen with cyclosporine in the post BMT period. If steroid use is required, the recommended schedule of Decadron dosing during the 6 week induction course is 8 mg/m2 divided q 6-8 hours.
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Children's Oncology Grouplead
- National Cancer Institute (NCI)collaborator
Study Sites (74)
University of Alabama Comprehensive Cancer Center
Birmingham, Alabama, 35294, United States
Arizona Cancer Center
Tucson, Arizona, 85724, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
University of California San Diego Cancer Center
La Jolla, California, 92093-0658, United States
Lucile Packard Children's Hospital at Stanford
Palo Alto, California, 94304, United States
Sutter Cancer Center
Sacramento, California, 95816, United States
Kaiser Permanente-Southern California Permanente Medical Group
San Diego, California, 92120, United States
Naval Medical Center - San Diego
San Diego, California, 92134-3202, United States
Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, 95051-5386, United States
Nemours Children's Clinic
Jacksonville, Florida, 32207, United States
Sylvester Cancer Center, University of Miami
Miami, Florida, 33136, United States
Baptist Hospital of Miami
Miami, Florida, 33176-2197, United States
Walt Disney Memorial Cancer Institute
Orlando, Florida, 32803, United States
St. Mary's Hospital
West Palm Beach, Florida, 33407, United States
Emory University Hospital - Atlanta
Atlanta, Georgia, 30322, United States
Tripler Army Medical Center
Honolulu, Hawaii, 96859-5000, United States
Rush-Presbyterian-St. Luke's Medical Center
Chicago, Illinois, 60612, United States
Children's Memorial Hospital, Chicago
Chicago, Illinois, 60614, United States
Christ Hospital
Oak Lawn, Illinois, 60453, United States
Saint Jude Midwest Affiliate
Peoria, Illinois, 61602, United States
University of Kansas Medical Center
Kansas City, Kansas, 66160-7357, United States
Via Christi Regional Medical Center-Saint Francis Campus
Wichita, Kansas, 67214, United States
Tulane University School of Medicine
New Orleans, Louisiana, 70112, United States
Eastern Maine Medical Center
Bangor, Maine, 04401, United States
Maine Children's Cancer Program
Portland, Maine, 04101, United States
Johns Hopkins Oncology Center
Baltimore, Maryland, 21287, United States
Floating Hospital for Children
Boston, Massachusetts, 02111, United States
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
Children's Hospital of Michigan
Detroit, Michigan, 48201, United States
St. John's Hospital and Medical Center
Detroit, Michigan, 48236, United States
Hurley Medical Center
Flint, Michigan, 48503, United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216-4505, United States
Keesler Medical Center - Keesler AFB
Keesler Air Force Base, Mississippi, 39534-2576, United States
University of Missouri-Columbia Hospital and Clinics
Columbia, Missouri, 65212, United States
Cardinal Glennon Children's Hospital
St Louis, Missouri, 63104, United States
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Norris Cotton Cancer Center
Lebanon, New Hampshire, 03756, United States
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
University of New Mexico School of Medicine
Albuquerque, New Mexico, 87131, United States
Roswell Park Cancer Institute
Buffalo, New York, 14263-0001, United States
State University of New York Health Sciences Center - Stony Brook
Stony Brook, New York, 11790-9832, United States
State University of New York - Upstate Medical University
Syracuse, New York, 13210, United States
Duke Comprehensive Cancer Center
Durham, North Carolina, 27710, United States
Oklahoma Memorial Hospital
Oklahoma City, Oklahoma, 73126-0307, United States
Natalie Warren Bryant Cancer Center
Tulsa, Oklahoma, 74136, United States
Medical University of South Carolina
Charleston, South Carolina, 29425-0721, United States
James H. Quillen College of Medicine
Johnson City, Tennessee, 37614-0622, United States
Saint Jude Children's Research Hospital
Memphis, Tennessee, 38105-2794, United States
Medical City Dallas Hospital
Dallas, Texas, 75230, United States
Simmons Cancer Center - Dallas
Dallas, Texas, 75235-9154, United States
Cook Children's Medical Center - Fort Worth
Fort Worth, Texas, 76104, United States
University of Texas Medical Branch
Galveston, Texas, 77555-1329, United States
Baylor College of Medicine
Houston, Texas, 77030, United States
San Antonio Military Pediatric Cancer and Blood Disorders Center
Lackland Air Force Base, Texas, 78236-5300, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78284, United States
Scott and White Clinic
Temple, Texas, 76508, United States
Vermont Cancer Center
Burlington, Vermont, 05401-3498, United States
Inova Fairfax Hospital
Falls Church, Virginia, 22046, United States
Carilion Roanoke Memorial Hospital
Roanoke, Virginia, 24029, United States
Madigan Army Medical Center
Tacoma, Washington, 98431-5000, United States
West Virginia University Medical School, Charleston Division
Charleston, West Virginia, 25304, United States
West Virginia University Hospitals
Morgantown, West Virginia, 26506-9162, United States
St. Vincent Hospital
Green Bay, Wisconsin, 54307-3508, United States
Midwest Children's Cancer Center
Milwaukee, Wisconsin, 53226, United States
Alberta Children's Hospital
Calgary, Alberta, T2T 5C7, Canada
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
Montreal Children's Hospital
Montreal, Quebec, H3H 1P3, Canada
Hopital Sainte Justine
Montreal, Quebec, H3T 1C5, Canada
Centre Hospitalier de L'Universite Laval
Sainte-Foy, Quebec, GIV 4G2, Canada
Academisch Ziekenhuis Groningen
Groningen, 9713 EZ, Netherlands
San Jorge Childrens Hospital
Santurce, 00912, Puerto Rico
Clinique de Pediatrie
Geneva, 1211, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mark L. Greenberg, MD
The Hospital for Sick Children
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Masking
- NONE
- Purpose
- TREATMENT
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 1999
First Posted
September 13, 2004
Study Start
December 1, 1998
Primary Completion
February 1, 2001
Study Completion
April 1, 2006
Last Updated
July 28, 2014
Record last verified: 2014-07